N🟁N

MTOR, MITI, GEOY, EBS, DVR, DCT Expected to Trade Up After Bullish Patterns Develop

October 14, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. MERITOR SAVINGS BANK (NYSE:MTOR), MICROMET INC (NASDAQ:MITI), GEOEYE INC (NASDAQ:GEOY), EMERGENT BIOSOLUTIONS, INC. (NYSE:EBS), CAL DIVE INTERNATIONAL INC (NYSE:DVR), DCT INDUSTRIAL TRUST INC (NYSE:DCT) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.

     Symbol     Company                             Strategy                            Pattern Name            Strength  
     MTOR       MERITOR SAVINGS BANK                Breakout (Stocks) DO                Trend Line Break(4)     5         
     MITI       MICROMET INC                        Breakout (Stocks) DO                Trend Line Break(5+)     5         
     GEOY       GEOEYE INC                          Breakout (Stocks) DO                Trend Line Break(3)     1         
     EBS        EMERGENT BIOSOLUTIONS, INC.         Breakout (Stocks) DO                Trend Line Break(3)     5         
     DVR        CAL DIVE INTERNATIONAL INC          Reversal (Stocks) DWC               Broadening Bottom       1         
     DCT        DCT INDUSTRIAL TRUST INC            Reversal (Stocks) DWC               Trend Line Break(3)     5         

Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php

MERITOR SAVINGS BANK (NYSE:MTOR) - MERITOR SAVINGS BANK

MICROMET INC (NASDAQ:MITI) - Micromet Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibodies for the treatment of cancer, inflammation, and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE antibody platform, as well as conventional monoclonal antibodies. The companys lead product MT103 is in Phase II clinical trial for the treatment of acute lymphoblastic leukemia, as well as in Phase I trial for non-Hodgkins lymphoma. Its Phase II trial product also includes MT201 for solid tumors; and Phase I trial products comprise MT110 and MT293 for solid tumors, and MT203 for the treatment of inflammatory diseases. The companys products in preclinical stage include MT111 to treat solid tumors; BiTE antibody for acute myelogenic lymphoma and solid tumors; MT228 for melanoma; and MT204 for the treatment of inflammatory diseases, including rheumatoid arthritis, asthma, acute transplant rejection, uveitis, psoriasis, and multiple sclerosis. It has license agreements and collaborations with Biovation Limited; Enzon Pharmaceuticals, Inc.; MedImmune LLC; Bayer Schering Pharma AG; TRACON Pharmaceuticals, Inc.; Nycomed A/S; Morphotek, Inc.; Sanofi-Aventis; and Boehringer Ingelheim. The company is headquartered in Bethesda, Maryland.

GEOEYE INC (NASDAQ:GEOY) - GeoEye, Inc., together with its subsidiaries, provides earth imagery and imagery information products, as well as image processing services to the United States and foreign government defense and intelligence organizations, domestic federal and foreign civil agencies, and commercial customers. The company owns and operates three earth-imaging satellites, which include GeoEye-1, IKONOS, and Orbview-2; and three fixed-wing aircraft with high-resolution imagery collection capabilities. The GeoEye-1 and IKONOS satellites principal applications include national security, mapping, oil and gas, infrastructure, mining, land use, and land planning; and Orbview-2 satellites applications primarily comprise weather, fishing, agriculture, scientific research, and environmental monitoring. The companys satellite imagery products include Geo, GeoProfessional, and GeoStereo that provide the customers with time-critical visual imagery, data, and information. Its aerial imaging products consist of digital aerial imaging and light detection and ranging imaging (LiDAR). The companys production services range from the generation of precision imagery products to the extraction of site-specific features for the companys customers database development. These production services include Georectification, Image Mosaicing, Tonal Correction, and Orthorectification; and LiDAR elevation data, maps, topographic maps, digital orthophoto imagery, remote sensing services, survey and inventory services, and geospatial information service consulting and implementation. It sells its products directly to end users or through resellers. GeoEye, Inc. is based in Dulles, Virginia.

EMERGENT BIOSOLUTIONS, INC. (NYSE:EBS) - Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the bodys immune system. The companys biodefense segment develops, manufactures, and commercializes drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients after they are exposed to anthrax and botulinum toxin. Emergents commercial segment develops products for use against infectious diseases. These include a single-dose typhoid vaccine in phase II clinical development; a hepatitis B vaccine in phase II clinical development, and a group B streptococcus vaccine for women of childbearing age for protection of the fetus and newborn babies, which is in phase I clinical trials. Emergent is also developing chlamydia and meningitis B vaccines. Emergent primarily works for the U.S. Defense and Health & Human Services departments. It has collaboration agreements with the British Health Protection Agency for the development of a human botulinum immune globulin candidate and with Sanofi Pasteur for the development of meningitis B vaccine candidate. The company, which was founded in 1998, is based in Rockville, Maryland.

CAL DIVE INTERNATIONAL INC (NYSE:DVR) - Cal Dive International Inc., a marine contractor, provides manned diving, pipe laying, and pipe-burial services to the offshore oil and natural gas industry. The company offers saturation, surface, and mixed gas diving services. Cal Dive also provides such diving-support services as construction, inspection, maintenance, repair, and decommissioning of offshore production and pipeline infrastructure on the Gulf of Mexico Outer Continental Shelf as well as in international offshore markets, including the Mideast, southeast Asia, and Australia. Its customers include oil and natural gas producers, pipeline transmission companies, and offshore engineering and construction outfits. As of Dec. 31, 2006, Cal Dive owned and operated a fleet of 26 vessels, including 23 surface and saturation diving support vessels as well as three shallow water pipe-laying vessels. The company, which was founded in 1975, is based in Houston.

DCT INDUSTRIAL TRUST INC (NYSE:DCT) - DCT Industrial Trust Inc. operates as a publicly owned real estate investment trust. The firm provides its services to companies. Through its fund, it engages in the ownership, operation, and development of real estate properties. The firm specializes in the ownership, acquisition, development, and management of institutional capital management program. It invests in the real estate markets of United States and Mexico. The firm is also invests in selected international markets. It primarily invests in commercial real estate properties, including generic distribution warehouses and light industrial properties. The firm was formerly known as Dividend Capital Trust Inc. DCT Industrial Trust was founded in 2002 and is based in Denver, Colorado with additional offices in Atlanta, Georgia and Dallas, Texas.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net